Bishop et al describe the previously untried use of intrapleural
Alteplase to treat a 16 month old child with a complex parapneumonic
effusion. While I recognise that they may have been unaware of the
randomised placebo controlled trial of intrapleural urokinase in the
management of empyema, published last year1. This trial showed convincing
evidence of benefit from urokinase, with few adverse effects. The median
length of stay in the treatment group was 7.4 days, which compares
favourably to the reported case. The best results have been found using
smaller pigtail catheters (e.g. 12 French)(1,2) rather than the 16 French
catheter used by Bishop.
While it is important to try new treatments for conditions where treatment
is ineffective, it is also crucial that these innovations are compared to
effective treatments which have been undergone adequate clinical trial.
References
1. Thomson A, Hull J, Kumar M, Wallis C, Balfour Lynn I, et al. Randomised
trial of intrapleural urokinase in the treatment of childhood empyema.
Thorax 2002;57:343-7.
2. Pierrepoint M, Evans A, Morris S, Harrison S, Doull I. Pigtail catheter
drain in the treatment of empyema thoracis. Archives of Disease in
Childhood 2002;87:331-2.